IL17A and arthritic joint disease: Following treatment, serum levels of IL-6 and IL-17A were considerably lower at all triptolide time points (Figures 3C,D), and intergroup comparisons revealed that the time of administration did not affect triptolide’s effect on arthritis score and IL-6 reduction in CIA mice (Figures 3B,C).